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ABSTRACT 
 
 
 
The present work deals with the preparation and study of bioceramic scaffold using 
hydroxyapatite powder as the source material. Hap powder was prepared by Co-Precipitation technique 
using Ca(NO3)2.4H2O and (NH4)2HPO4 as raw materials. X-ray diffraction (XRD), Fourier Transform 
InfraRed (FTIR) spectroscopy and BET analysis were used to characterize the Hap powder and calculate 
its crystallite size, surface area and particle size. Polyethylene glycol (PEG – 600) was used as the pore 
former to produce the bioceramic scaffold. Bulk density, apparent porosity and compressive strength of 
the scaffold were calculated. Thereafter, characterization techniques like Mercury Intrusion Porosimetry 
and Scanning Electron Microscopy (SEM) were carried out to study the macro/micro pores and 
microstructure of the scaffold in detail. In the end, in-vitro bioactivity using SBF was done which was 
followed by a detailed SEM study of the SBF-treated scaffold which showed the growth of tissue over the 
scaffold surface. 
 
 
 
 
 
 
 
 
i 
 
  
 
1. INTRODUCTION 
 
 
               1.1 Bone 
                                                         
1.2 Bone Tissue Engineering 
 
1.3 Scaffold Design 
 
1.4 Present Project  
  
1.4.1  Objective 
 
1.4.2  Why use Hap for preparation of  
          scaffold ? 
                             
1 
 
 
1.1 Bone 
Bone is a specialized connective tissue with mineralized extracellular marix (ECM). Bone grafting 
is routinely performed to restore bone loss due to trauma or disease. It is well known that hydroxyapatite 
(Hap) is the major component of natural bone mineral and has been found to possess good mechanical 
properties, biocompatibility, and osteoconductivity [1]. For these reasons, sintered Hap or other calcium 
phosphate apatites have been widely used for repair and replacement of damaged or traumatized bone 
tissues [2-4]. However, these materials have major disadvantages for tissue engineering applications: 
they are lack of desired degradability in a biological environment, are brittle, and their processing capacity 
into a predesigned highly porous structure is limited.  
 There is a growing need for bone regeneration due to various clinical bone diseases such as 
bone infections, bone tumors and bone loss by trauma [5]. Current therapies for bone defects include 
autografts, allografts, xenografts and other artificial substitutes such as metals, synthetic cements and 
bioceramics [6-7]. However, these substitutes are far from ideal and each has its specific problems and 
limitations. For example, autografts are associated with donor shortage and donor site morbidity whereas 
allografts and xenografts have the risk of disease transmission and immune response [8], and synthetic 
materials wear and do not behave like true bone. 
 
1.2 Bone Tissue Engineering 
Bone tissue engineering is an increasingly important research area whose goal is to surpass the 
limitations of conventional treatments based on organ transplantation and biomaterial implantation [9]. 
There are three general approaches in tissue engineering [10] : 
• the use of isolated cells or cell substitutes to replace those cells that supply the needed function; 
• the delivery of tissue-inducing substances, such as growth and differentiation factors to targeted   
  locations; 
• growing cells in three-dimensional scaffolds. 
The third approach has seen significant research developments. Porous matrices, known as scaffolds, to 
which cells attach and colonize, play a vital role in synthesizing bone–extracellular matrix and associated 
biological molecules to facilitate the formation of functional tissues/organs. Scaffolds for bone 
regeneration should meet criteria to serve this function, these include [11] :                                                
 a high porosity and appropriate pore size; 
 a high surface area is required;                 2 
 biodegradability is generally required and a degradation rate is needed to match the rate 
of tissue formation; 
 mechanical integrity to maintain the pre-designed tissue structure; 
 biocompatibility (i.e. non-toxic to cells); 
 the scaffold should display a positive interaction with cells, that may include enhanced 
cell adhesion, proliferation, migration, and differentiation; 
 scaffolds are also used as carriers for the delivery of growth and differentiation factors, 
e.g., the factors can be adsorbed on the surface of the scaffold. 
These scaffold requirements are extremely complex and tissue-specific to the structure and function of 
the host tissue. Creating scaffolds and engineering bone tissues that meet the needs of specific repair 
sites in particular patients is a major challenge in the field of bone tissue engineering research. 
 
1.3 Scaffold Design 
In bone regeneration, scaffolds serve as a template for cell interactions and formation of bone 
extracellular matrix to provide structural support to the newly formed tissue. Therefore, it is necessary that 
the scaffolds should, in some respects, mimic host bone morphology in order to optimise integration into 
surrounding tissue. Porosity is defined as “the percentage of void space in a solid and it is a 
morphological property independent of the material” [12]. Pores are necessary for bone tissue formation 
because they allow migration of endothelial cells: to promote osteoblasts or progenitor cells; to promote 
vascularisation of mesenchymal cells; or to facilitate osteoblast proliferation and differentiation (i.e. 
osteogenesis). In addition, a porous surface improves mechanical stability and interlocking at the critical 
interface between the implant biomaterial and the surrounding natural bone. The minimum pore size 
required to regenerate mineralized bone is generally considered to be approx. 100 µm after the study of 
Hulbert et al. [13]. 
 Relatively larger pores favour direct osteogenesis, since they allow vascularisation and high 
oxygenation, while smaller pores result in osteochondral ossification although the type of bone in-growth 
depends on the biomaterial and the pore geometry. Moreover, porosity and pore size properties influence 
mechanical properties. An increase in the void volume results in a reduction in mechanical strength and 
stiffness of the scaffold, which can be critical for regeneration in load-bearing bones. The extent to which 
pore size can be increased while maintaining mechanical requirements, is dependent on a number of 
factors including the nature of the biomaterial and the processing conditions used in the fabrication of 3D 
scaffolds [14].                       
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1.4 Present Project 
1.4.1  Objective 
 The principal objectives of this project were as follows : 
 To prepare phase pure Hap by co-precipitation method involving CaNO3.4H2O and 
(NH4)2HPO4. 
 To achieve stability of the above Hap powder’s calcined form at higher temperatures, 
upto 1250
0
C. 
 To prepare Hap scaffolds having various degrees of porosities and study their bulk 
densities and compressive strengths. 
 To study the nature of pores in the scaffolds by studying their porosimetry curves and 
microstructures. 
 To study the changes on the surface of the scaffolds after treating them with SBF for 
considerable amount of time. 
  
1.4.2 Why use Hap for preparation of scaffold ? 
 Hydroxyapatite [Ca10(PO4)6(OH)2] is one of the most biocompatible ceramics because of its 
significant chemical and physical resemblance to the mineral constituents of human bones and teeth. It is 
a bioactive ceramics widely used as powders or in particulate forms in various bone repairs and as 
coatings for metallic prostheses to improve their biological properties. It has excellent biocompatibility, 
bioactivity and osteoconduction properties. Hap is thermodynamically the most stable calcium phosphate 
ceramic compound nearest to the pH, temperature and composition of the physiological fluid.  
 Due to the chemical similarity between Hap and mineralized bone of human tissue, synthetic Hap 
exhibits strong affinity to host hard tissues. Formation of chemical bond with the host tissue offers Hap a 
greater advantage in clinical applications over most other bone substitutes, such as allograft or metallic 
implants. 
 
Porous Hydroxyapatite 
Porous Hap exhibits strong bonding to the bone; the pores provide a mechanical interlock leading 
to a firm fixation of the material. Bone tissue grows well into the pores, thus increasing strength of the 
Hap implant. The ideal bone substitute is a material that will form a secure bond with the tissues by 
allowing, and even encouraging, new cells to grow and penetrate [14].               4 
One way to achieve this is to use a material that is osteophilic and porous, so that new tissue, 
and ultimately new bone, can be induced to grow into the pores and help to prevent loosening and 
movement of the implant. A porous hydroxyapatite coating facilitates bone growth through a highly 
convoluted interface. When pore sizes exceed 100 μm, bone grows through the channels of 
interconnected surface pores, thus maintaining the bone's vascularity and viability. Since porous Hap is 
more resorbable and more osteoconductive than dense Hap, there is an increasing interest in the 
development of synthetic porous hydroxyapatite (Hap) bone replacement materials for the filling of both 
load-bearing and non-load-bearing osseous defects. Simulating the human bone structure, porous Hap 
scaffold has large surface area, which is beneficial for adhesion of biological tissue cell and growth of new 
bone phase [15].  
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2.1 Bioceramics – A subset of Biomaterials 
The first generation of inert ceramics aimed to substitute natural bone, hence the research was 
only focused on inert materials; the second one was aimed at mimicking some biomineralization-related 
functions and sol-gel chemistry plays a paramount role in their synthesis and properties. Finally, the 
purpose with third generation bioceramics is basically to provide an adequate scaffolding system which 
helps the bone cells to perform their natural processes [16]. 
 Imperial Roman empire folks had a very low life expectancy of just 22 years which almost 
doubled to 40 years by the early 20
th
 century and now we are comfortably boasting of a great 80 years of 
life expectancy by the end of this 20
th
 century. Biomaterials have made all the difference. If we focus on 
functional artificial biomaterials, the choice has to be made among metals, polymers and ceramics. Each 
group exhibits some a priori advantages and drawbacks. Ceramics, for instance, are the most 
biocompatible materials and can be obtained with biostable, bioactive or bioresorbable properties, but 
their main drawbacks are their hardness and fragility. Metals exhibit problems of corrosion and toxicity, 
but their mechanical behavior is optimum. Polymers offer many possibilities depending on their chemical 
composition and structure (biodegradability degree, hydrophilic/ hydrophobic ratio, toughness/flexibility, 
etc.), but very few have shown good bioactive properties (for instance, Poliactive1) to ensure the implant 
osteointegration. Therefore, it is important to reach the best compromise possible, and it is quite usual to 
use the three types of materials in the same implant. This is the case of a total hip joint prosthesis which 
presents a metal beam, partially coated with a bioactive ceramic, while the head is made of an inert 
ceramic and the socket is made of polymer [17]. 
 
2.2 Hydroxyapatite 
The inorganic phase of our bones is apatite. Apatite is the term of a very abundant mineral in the 
earth’s crust, with Ca10(PO4)6(OH)2, {more commonly known as Hydroxyapatite (Hap)} as general formula 
[18]. Its structure has the special ability to accommodate several different ions in its three sublattices 
[19,20]. Bone apatites can be considered as basic calcium phosphates. Biological apatites are formed in 
living bodies through a biomineralisation process where cells and proteins are involved. 
 
2.3 Bioceramic Scaffolds 
In order to work in potential hard tissue replacement solutions, it is required to know and bear in 
mind the bone regeneration process. Wolf’s law dictates that the bone remodels itself as a function of     7 
those forces acting on it, hence preserving its shape and density. The mechanical loads of stress, 
compression, flex and torsion in bones and the interstitial fluid contained in them generate stresses and 
deformations at the microscopical level, which in turn stimulate the cells [21]. 
 The fabrication of scaffolds for tissue engineering requires choosing a conformation method that 
yields pieces with interconnected porosity and pores in the 20 to 400 micron range [22]. The main 
purpose now is to obtain porous ceramics that act as scaffolds for cells and inducting molecules, able to 
drive self-regeneration of tissues.  
Polymer scaffolds were used as negative of the desired ceramic piece. After conforming the 
piece, the polymer is removed by an acid or basic attack, or using mild temperatures. These pieces, with 
designed porosity, preserve their bioactive behavior, where apatite has grown throughout all the free 
surfaces [23, 24]. 
An important challenge is to design materials that can help the human body to improve its 
regeneration features, not only recovering the structure of the damaged tissue, but also its function [25]. 
Tissue engineering aims to restore the structure and function of the tissues or damaged organs. The 
repair starts by in vitro techniques on scaffolds cultured with cells, to be then implanted in the host [26]. 
 
2.4 Processing of Bioceramic Materials  
Sopyan et al. [27] studied porous hydroxyapatite for artificial bone applications. It was reported 
that the preparation of Hap porous bodies via polymeric sponge method; the samples of which were 
prepared using sol–gel method-derived Hap powders and commercial Hap powders showed a 
considerable compressive strength ranging from 1.3 to 10.5 MPa for the increased apparent density from 
1.27 to 2.01 g/cm
3
. This was higher than the 0.55–5 MPa compressive strength obtained for the apparent 
densities of 0.0397– 0.783 g/cm
3
, as reported by Ramay et al. [28].  It was also shown that homogeneity 
of slurry and heating rate affected porosity and density of porous bodies, in turn influencing the 
compressive strength. More homogeneous slurries and faster heating rate gave porous bodies with the 
increased compressive strength due to higher apparent density and crystallinity. 
 Potoczek [29] studied the gel casting of hydroxyapatite foams using agarose as gelling agent and 
the rheological behavior of the suspensions. The viscosity of the slurries could be adjusted by agarose 
concentration and Hap solid loading. These parameters were essential in tailoring the porosity as well as 
the cell and window sizes of the resulted Hap foams. Depending of Hap solid loading (24–29 vol.%) and 
agarose concentration (1.1–1.5 wt.% with regard to water) in the starting slurry, the mean cell size ranged 
from 130 to 380 μm, while the mean window size varied from 37 to 104 μm. Depending on the porosity   8                                                                                                                              
range (73–92%) and related with this parameter the mean cell and window size, the compressive strength 
of Hap foams was found to be in the range 0.8–5.9 MPa.  
Schwartzwalder and Somers [30] studied the slurry infiltration process for making porous 
ceramics. In this process poly urethane (PU) foam was infiltrated with ceramic slurry and the body was 
compressed by passing it through a set of rollers to remove the excess slurry. In this manner the slurry 
remained coated on the PU struts and open pore channels were left in between. The coated PU perform 
was then dried, followed by burn out of the PU and sintering at higher temperature. The foams produced 
were reticulated foams with porosity within the range 75-90%. 
 Thijs et al. [31] studied a novel technique to produce macroporous ceramics using seeds and 
peas as sacrificial core materials. The first step in this technique was to coat the seeds, peas with wetting 
ceramic slurry that undergoes gelation. The coated seeds and peas were consolidated by packing them 
in a container and infiltrating with ceramic slurry which underwent gelation. The compacts thus obtained 
were subjected to the conventional steps of drying, binder burn out and sintering. The resulting bodies 
had greater than 90% porosity with pore size determined by the size of the seeds, peas. 
 Itatani K et al. [32] studied the preparation of Porous Hydroxyapatite Ceramics from Hollow 
Spherical Agglomerates Using a Foaming Agent of H2O2 and observed that by changing the 
concentration of H2O2 solution from 0 to 20 mass%, the total porosity of Hap compact fired at 1000
0
C for 
5 hrs could be changed linearly from 61.2 to 71.7%. The Hap compact exhibited pore sizes with 
maximum porosity (71.7%) at around 0.7 μm, 5-100 μm and 100-200 μm. 
 Soon-Ho kwon et al. [33] successfully fabricated porous bioceramics with variable porosity, using 
the poly urethane sponge technique. Porosity was controlled by the number of coatings on the sponge 
struts. When a porous body was produced by a single coating, the porosity was ~90%, and the pores 
were completely interconnected. When the sintered body was coated five times after the porous network 
had been made, the porosity decreased to 65%. The compressive strength was strongly dependent on  
the porosity and weakly dependent on the type of ceramics, Hap, TCP, or Hap/TCP composite. At the 
65% porosity level, the strength was ~3 MPa. The TCP exhibited the highest dissolution rate in a Ringer’s 
solution, Hap had lowest rate. The biphasic Hap/TCP showed an intermediate dissolution rate. The 
biodegradation of calcium phosphate ceramics could be controlled by simply adjusting the amount of Hap 
or TCP in the ceramic. Han Guo et al. [34] studied biocompatibility and osteogenicity of degradable Ca-
deficient hydroxyapatite (CaD Hap) scaffolds from calcium phosphate cement for bone tissue engineering 
by a particle leaching method. The morphology, porosity and mechanical strength as well as degradation 
of the scaffolds were characterized. The results indicated that the CaD Hap scaffolds with a porosity of 
81% showed open macropores with pore sizes of 400–500 μm. Thirty-six per cent of these CaD Hap 
scaffolds were degraded after 12 weeks in Tris–HCl solution. The results revealed that the CaD Hap 
scaffolds were biocompatible and had no negative effects on the mesenchymal stem cells (MSCs) in      9 
vitro. The in-vivo biocompatibility and osteogenicity of the scaffolds were investigated. The CaD Hap 
scaffold after 8 week implantation shows good biocompatibility and extensive osteoconductivity. 
 Deville et al. [35] studied the freeze casting of porous hydroxyapatite scaffolds and observed that 
by varying the freezing rate of slurry as well as slurry concentration, porosities in the range 40-60% could 
be achieved. The pores were open and unidirectional and exhibited a lamellar morphology. The 
processed scaffolds exhibited high compressive strength up to 145 MPa. 
 Xiao Huang et al. [36] studied the Hap-based composite scaffolds that have a unique 
macroporous structure and special struts of a polymer/ceramic interpenetrating composite. A novel 
combination of polyurethane (PU) foam method and a hydrogen peroxide (H2O2) foaming method is used 
to fabricate the macroporous HA scaffolds. Micropores are present in the resulting porous Hap ceramics 
after the unusual sintering of a common calcium phosphate cement and are infiltrated with the poly(D,L-
lactic-co glycolic acid) (PLGA) polymer. The internal surfaces of the macropores are further coated with a 
PLGA bioactive glass composite. It is found that the HA scaffolds fabricated by the combined method 
show high porosities of 61–65% and proper macropore sizes of 200–600 μm. The PLGA infiltration 
improved the compressive strengths of the scaffolds from 1.5–1.8 to 4.0– 5.8 MPa. 
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3.1 Preparation of Hydroxyapatite  
Solution-precipitation method, also known as Co-Precipitation Method was applied using 
Ca(NO3)2·4H2O (Merck, India) and (NH4)2HPO4 (Merck, India) as the starting materials and Ammonia 
(NH3) solution(Merck, india). A solution of 1M Ca(NO3)2·4H2O was prepared at 25
0
C.  
 
3.1.1 Estimation of {Ca(NO3)2.4H20}  
3 ml of Ca(NO3)2.4H20 was pipette out into a beaker and it was titrated against 2.5 M NaOH 
solution. The precipitate was filtered and the residue was calcined at 1000
0
C at a rate of 3
0
C/min. for 2 
hours. 
Calculations : 
Wt. of empty Al2O3 crucible – 1 – 140.0463 gm (WE1). 
Wt. of empty Al2O3 crucible – 2 – 152.7539 gm (WE2). 
Wt. of empty Al2O3 crucible – 3 – 136.0114 gm (WE3). 
 
Wt. of (sample + crucible) – 1 – 140.1694 gm (WS1) 
Wt. of (sample + crucible) – 2 – 152.8769 gm (WS2) 
Wt. of (sample + crucible) – 3 – 136.1349 gm (WS3) 
 
Wt. of CaO – 1 – WS1 – WE1 = 140.1694 – 140.0463 = 0.1231 gm. 
Wt. of CaO – 1 – WS2 – WE2 = 152.8769 – 152.7539 = 0.1230 gm. 
Wt. of CaO – 1 – WS3 – WE3 = 136.1349 – 136.0114 = 0.1235 gm. 
 
 
3 ml of Ca(NO3)2.4H2O contain CaO = {(0.1231 + 0.1230 + 0.1235) / 3} gm = 0.1232 gm. 
So, 1 ml of Ca(NO3)2.4H2O contains CaO = 0.1232 / 3 = 0.0411 gm. 
 0.0411 gm of CaO from 1 ml of Ca(NO3)2.4H2O 
 
 1 gm of CaO from (1 / 0.0411) ml of Ca(NO3)2.4H2O = 24.3309 ml. 
                   
12 
3.1.1.1 Reactions 
 
Ca(NO3)2 + 2NaOH                                                          Ca(OH)2 + 2NaNO3 
 
850
0
C, 2hrs / 3
0
C / min
-1
 
Ca(OH)2 
 
                                                           CaO + H2O 
 
3.1.2 Batch Calculation  
We tested a 10 gm batch. Hydroxyapatite is given by the formula Ca10(PO4)(OH)2 (Hap). 
Ca / P ratio = 10/6 = 1.67 
 
For 1 mole of Hap  6 moles of phosphate required. 
Molecular Wt. of (NH4)2HPO4 = 132.06 gm 
Molecular Wt. of Hap = 1004 gm 
 
Therefore 1004 gm of Hap requires 6 x 132.06 gm of phosphates = 792.36 gm of phosphates 
 10 gm of Hap requires {(792.36 / 1004) x 10} = 7.8884 gm of (NH4)2HPO4. 
 
NH4OH = 480 ml (1:1) solution. 
 
(NH4)2HPO4 = 7.8884 gm / 40 ml of distilled H2O. 
 
CaO required = {1.67 x 7.8884 x 56.08} / 132.06 = 5.5943 gm 
Total Ca(NO3)2.4H2O required = (5.5943 x 24.3309) ml = 136.1144 ml. 
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3.1.3 Synthesis of Hydroxyapatite  
 
3.1.3.1 Procedure 
The Ca:P ratio for stoichiometric HA =1.67. Keeping that ratio constant, the amount of 
(NH4)2HPO4 required was calculated and it was prepared by dissolving (NH4)2HPO4  in distilled water. The 
prepared solution of (NH4)2HPO4  was slowly added to the Ca(NO3)2.4H2O solution (in stirring condition) 
resulting in the formation of a turbid solution. Conc. HNO3 was added and the resulting solution was 
shaken well for a few minutes till a colourless solution was obtained. Then 1:1 NH3 solution (NH4OH) was 
added drop wise and stirred and continuously till the Hap white precipitate was formed. The pH in the 
entire experiment was maintained at 10.4. The Hap ppt. was stirred (magnetic stirrer) for 2-3 hours and 
the precipitate was aged for overnight for settling of the precipitates followed by decantation and removal 
of ammonia by repeated washing of the precipitate with distilled water. 
The settled material was centrifuged with the help of a High – Speed Centrifuger (rotational speed 
of 8000 rpm). The ppt. left out was dried at 85
0
C for 24 hours and then the dried mass was calcined at 
850
0
C for 2 hrs at 3
0
C/min. 
 
3.1.3.2 Reaction 
 
 10Ca(NO3)2.4H2O + 6(NH4)2HPO4 + 8NH4OH  Ca10(PO4)6(OH)2 + 20NH4NO3 + 46H2O 
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3.1.4 Flowchart of Hap synthesis  
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Ca(NO3)2.4H2O (NH4)2HPO4 
Turbid solution 
Colorless solution 
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0
C 
NH4OH removal 
(washing) 
Ppt. settles down 
White Ppt. 
Conc. 16M 76% 
HNO3 
1:1 NH3 solution 
Continuous 
stirring (2 hrs) 
Crushing into fine 
powder 
Calcination at 
850
0
C 
Calcined Hap 
powder 
3.2 Characterisations for synthesized and calcined Hap  
The following characterizations were done after calcinations of Hap powder : 
 X-Ray Diffraction (XRD) Analysis of calcined Hap by PANAnalytical XRD machine from 
Philips, Netherlands. The incident angle (Ѳ) varied between 20
0
 and 80
0
. λ of Cu Kα 
radiation was 1.54 A
0
. The Hap peaks were identified using JCPDS file (reference 
number – 74-0565). 
 Fourier Transform InfraRed Spectroscopy (FTIR) of synthesized and calcined Hap by 
FTIR instrument of Perkin-Elmer. 
 BET Analysis of synthesized and calcined Hap by BET machine of Quantachrome, USA. 
 Particle Size Analysis of both synthesized and calcined Hap by Zetasizer Nano Series, 
Nano ZS of MALVERN. 
 
3.3 Preparation of Hap Scaffold using PEG-600 (Pore Former) 
The objective was to prepare bioceramic Hap scaffolds each with a different amount of porosity. 
Hence required amounts (as given in the following table) of calcined Hap powder and Polyethylene Glycol 
(PEG – 600), here 600 being the molecular mass of PEG used in this project, were first taken and mixed 
after weighing in the required materials using an electronic weighing machine. 
 
Table 3.1. Weights of Calcined Hap and PEG – 600 used to prepare Hap scaffolds. 
Wt. of Calcined Hap (gms) Wt. of PEG – 600 (gms) 
1 0.48 
1 0.52 
1 0.60 
1 0.80 
1 1.40 
1 2.40 
        16 
Mixing was done using a mortar and pastel. Three samples of each mixture were taken and 
pelletized using the Carver Pelletising Machine at a pressure of 5 Tonnes for 2 mins. 
 The pellets were then dried at 85
0
C for 24 hours and then sintered at 1250
0
C keeping the soaking 
time as 4 hours to produce the required scaffolds. 
 
3.4 Characterizations of Hap Scaffold  
 A few measurements and characterizations were done of the scaffolds which were produced. 
Measurements : 
 Bulk Density (B.D.) and Apparent Porosity (A.P.) by wet – analysis method (Archimedes’ 
Principle). 
B.D. and A.P. of scaffold was measured by applying Archimedes’ principle. Dry weight of 
sample was taken then samples were kept inside a beaker filled with kerosene and it was kept 
inside a desiccator for half an hour. Then suspended as well as soaked weight of samples was 
taken. 
A.P. and B.D. were represented as : 
 A.P. (%)    = {(W – D) / (W – S)} x 100 
 B.D. (g/cc) = {D / (W – S)} x d 
Where, W = Soaked weight of the sample, 
 S = Suspended weight of the sample, 
 D = Dry weight of the sample, 
 d = Density of kerosene (0.81 g/cc). 
 
 Compressive Strength  
The compressive strength of the sintered samples was measured by universal testing 
machine (H10 KS TINIUS OLSEN). The circular pellets (diameter d, thickness t) were broken in 
compression. The compressive strength of the pellets was determined from the following formula :   
                            17 
For circular pellets :  
  Compressive Strength (σ) = (2 x P) / (π x d x t), 
Where P = load in kN, 
       d = diameter of pellet, 
       t  = thickness of pellet. 
Characterisations : 
 Porosimetry using Mercury Intrusion Porosimeter. 
 Scanning Electron Microscopy (S.E.M.) using JEOL JSM – 6480 LV SEM and EDAX machine 
(Pt coating of 20 A
0
 on each sample using JEOL JFC – 1600 Auto Fine Coater). 
 
3.5 Bioactivity of Hap Scaffold using SBF 
 Each scaffold pellet (one each of different porosities) was dipped in SBF (Simulated Body Fluid) 
solution and kept in the B.O.D. incubator at 37
0
C and pH = 7.4 for 33 days. The SBF solution was 
replenished every 7 days. 
Table 3.2 SBF composition [38] :-  
Sl. No. Reagent Amount (gms/litre) 
1 NaCl 6.547 
2 NaHCO3 2.268 
3 KCl 0.373 
4 Na2HPO4.2H2O 0.178 
5 MgCl2.6H2O 0.305 
6 CaCl2.2H2O 0.368 
7 Na2SO4 0.071 
8 (CH2OH)3CNH2 6.057 
 
The samples were taken out, dried for 12 hours and then another SEM study was done of these 
SBF – treated pellets to study the surface changes in the scaffolds. 
 Details of all of the above mentioned measurements and characterizations are given in the next 
section of this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
19 
 4. RESULTS & DISCUSSIONS 
 
4.1 Hydroxyapatite Characterizations 
   
  4.1.1  XRD Analysis of Hap  
 4.1.1.1  Synthesized Hap 
4.1.1.2  Calcined Hap 
4.1.1.3  Sintered Hap 
4.1.1.4  Particle size Calculation 
   4.1.2  FTIR of Hap Synthesized 
   4.1.3  BET Analysis of Hap Calcined 
 
4.2 Hap Scaffolds’ Characterizations 
    
   4.2.1  Apparent Porosity and Bulk Density 
    4.2.2  Compressive Strength 
    4.2.3  SEM of Hap Scaffolds 
     4.2.4  Pore Distribution Analysis 
    4.2.5  In-Vitro Bioactivity 
    4.2.5.1  SEM 
    4.2.5.2  EDAX                  
 
 
          20 
4.1 Hydroxyapatite Characterizations 
 
4.1.1 X-Ray Diffraction (XRD) Analysis of Hap  
4.1.1.1 Synthesized Hap 
 
Fig. 4.1  XRD pattern of synthesized Hap 
4.1.1.2 Calcined Hap 
 
Fig. 4.2  XRD pattern of calcined Hap at 850
0
C 
21 
4.1.1.3 High Temperature XRD of calcined Hap 
 
Fig. 4.3  XRD pattern of Hap at 1250
0
C 
Fig. 4.1, Fig. 4.2 and Fig. 4.3 show the XRD patterns of synthesized Hap, calcined Hap (850
0
C) 
and high temperature stability behavior of Hap at 1250
0
C prepared by co-precipitation method. The Hap 
peaks were identified by referring JCPDS files (Ref No. 74-0565). 
The XRD pattern shows that the calcined powder contains only hydroxyapatite. No extra peaks 
were found. Thus the synthesized Hap powder was phase pure upto 1250
0
c without decomposition to β-
TriCalcium Phosphate (TCP). The peaks were sharper as the synthesized powder was calcined and in 
the end, sintered. It showed that the crystallinity of the powder increased at each following step.  
 
4.1.1.4 Crystallite size calculation 
We know that 
t = (0.96 x λ) / (β x cos Ѳ) , where t = particle size, 
      λ = wavelength of Kα – Cu used = 1.54 A
0
 
      β = Full Width Half Maximum (FWHM) 
      Ѳ = Incident Angle 
                    22 
So, t = {0.96 x 1.54} / {0.001373 x cos (31.8019 / 2)} 
         = 1120 A
0 
= 112 nm. 
 
 
4.1.2 Fourier Transform Infrared Spectroscopy (FTIR)  
 
Fig. 4.4  FTIR pattern of synthesized Hap 
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Table 4.1  Wavenumbers corresponding to their respective functional groups in FTIR   
                 spectroscopy 
  
Wave number (cm
-1
) Functional Group 
3562.95 OH - 
2357.07, 2329.94 CO3
2-
 (C=O) 
1179.95 C - O 
1644.13, 1420.61 NO3 
-
 
960.13, 630.74 PO4
3-
 
 
 Wavenumbers greater than 1400 cm
-1
 constitute the stretched bands and less than 1400 cm
-1 
are 
the bending bands of the functional groups. Thus it was seen that OH – and PO4
3-
 functional groups were 
least transmitted denoting their large presence in the material tested (Hap here). 
 
4.1.3 Surface Area Analysis of Hap 
 
BET Equation : 
1 / [ v { (P0/P) – 1]  =  { (c – 1) / vm x c}  +  1 / (vm x c) 
where,  v  = adsorbed gas quantity (volume units), 
 P  = equilibrium pressure of adsorbate, 
 P0 = saturation pressure of adsorbate, 
 c   = BET constant, 
 vm = monolayer adsorbed gas quantity.  
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 Fig. 4.5  BET plot 
From this plot, we find the following details : 
  Slope of the plot = A = 276.2, 
  Y – intercept = I = 6.034. 
So, calculating v and c, we have :- 
 v = {1 / A + I}    c = {1 + (A / I)} 
    = {1 / (276.2 + 6.034)}      = {1 + (276.2 / 6.034)} 
    = 3.54 x 10
-3
.       = 46.77 
 
Now, we know that  
 Stotal = (vm x NA x s) / V  where, NA = avogadro’s Number, a = mol. Wt.(adsorbed species) 
 SBET = Stotal / a    s  = adsorption cross-section. 
So, Stotal = {3.54 x 10
-3
 x (6.22 x 10
23
) x (16.2 x 10
-20
)} / 0.8865} 
              = 403.02 m
2
. 
Hence SBET = 403.02 / 28.0134 = 12.34 m
2
/g.                25 
We found the particle size (t) by the following formula : 
 t = { 6 / ( ρ x SBET ) 
   = { 6 / ( 3.16 x 12.34 ) 
   = 0.15387 µm 
   = 153.87 nm. 
The particle size found by the above mentioned BET method varied slightly with the data obtained from 
the Paticle Size Analyzer (PSA) value which stood at 121.8 nm. 
          
4.2 Hap Scaffolds’ Characterizations 
 
4.2.1 Apparent Porosity and Bulk Density 
 The following table gives the values of Apparent Porosity and Bulk Density of various scaffolds 
prepared by varying the calcined Hap / PEG – 600 ratio. 
 
Table 4.2 Apparent Porosity and Bulk Density of Hap scaffolds containing various concentrations  
                of pore former PEG – 600. 
Wt. of Hap (gms) Wt. of PEG (gms) Apparent Porosity (%) Bulk Density (g/cc) 
1.0 0.48 9.80 2.8563 
1.0 0.52 20.67 2.4811 
1.0 0.60 48.16 1.6410 
1.0 0.80 54.73 1.4347 
1.0 1.40 66.32 1.0659 
1.0 2.40 76.07 0.7387 
        26 
 The above data show that increase in pore former amount (PEG -600) leads to increase in the 
apparent porosity of the scaffold but it is simultaneously accompanied with decrease in its bulk density. 
Pore formation is followed by the mechanism of diffusion of pore former PEG-600. 
 
4.2.1 Compressive Strength (C.S.) 
 It is calculated by the formula :-  
C.S. = (2 x P) / (π x d x t)      
                            
Table 4.3 Compressive Strengths of Hap scaffolds containing various concentrations of pore –  
                 former PEG – 600. 
Wt. of Hap  
(gms) 
Wt. of PEG  
(gms) 
Diameter d  
(mm) 
Thickness t 
(mm) 
Load P 
(N) 
Compressive  
Strength (MPa) 
1.0 0.48 9.22 2.25 289 8.873 
1.0 0.52 8.80 2.22 98 3.809 
1.0 0.60 10.36 1.93 117 1.864 
1.0 0.80 10.32 1.97 93.3 1.462 
1.0 1.40 9.94 2.69 57 0.679 
1.0 2.40 9.96 1.96 11 0.179 
 
The above table clearly denotes that more the amount of pore-former, more is the porosity and 
hence, less is the compressive strength. 
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Fig. 4.6  Change of compressive strength w.r.t apparent porosity                               
Fig. 4.6 above shows that compressive strength decreases with increase in porosity as more 
porosity leads to loss of matter content and hence the loss in the strength of the sample(s). 
4.2.3 SEM of Hap Scaffolds 
Microstructures of the Hap scaffolds prepared by Co-Precipitation Method were studied from the 
Scanning Electron Microscopy (SEM) images as shown below. 
                  
                                          (a)                                                                (b)                                  
Fig. 4.7 SEM images of Hap scaffolds prepared by Co-Precipitation Method. (a) 9.80% porosity,  
             (b) 20.67% porosity.                  28 
                   
                                              (a)       (b)                                            
                  
          (c)      (d) 
       Fig. 4.8 SEM images of (a) 48.16%, (b) 54.73%, (c) 66.32%, (d) 76.07%  porous scaffolds 
 
It was seen that both macropores and micropores were interconnected. As the porosity 
increased, the number of interconnected pores increased. The pores were in the order of 100 – 400 µm. It 
was also seen that the size of the pores increased as the porosity increased. 
So, although increase in porosity lead to increase in the pore-size but it decreased the total 
number of pores in a cross-section as clearly seen in the SEM images of Fig. 4.8. 
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4.2.4 Pore Distribution Analysis 
 Porosimetry was done for the scaffold with 48% porosity and its pore distribution analysis was 
done. 
 
     
Fig. 4.9 Hg-intrusion study with respect to pore diameter in the scaffold with 48.16% porosity 
              
 Larger pores with pore diameter greater than 200 µm were analyzed by SEM study which follows 
this discussion here. However, Mercury Intrusion Porosimeter detected  the content of smaller pores 
within the range of 2 – 50 µm. 
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4.2.5 In-Vitro Bioactivity 
4.2.5.1 SEM 
When porous Hap was treated in SBF solution, the mechanism which followed was presumably 
along the lines as discussed by Huang et al [36], who believed that at first, on soaking in SBF, the 
surface structural change occured in Hap resulting in the formation of a Ca-rich Amorphous Calcium 
Phosphate (ACP) on their surfaces. In view of change in Ca/P ratio, the formation of Ca-rich ACP was a 
consequence of interaction of the Hap surface, specifically with the calcium ions in the SBF. The second 
surface structural change was the formation of Ca-poor ACP, for which the Hap appeared to use the Ca-
rich ACP on their surfaces to interact with the phosphate ions in the fluid. The third surface structural 
change was the formation of apatite. The Ca-poor ACP on the Hap appeared to gradually crystallize into 
bonelike apatite, through which the Hap appeared to stabilize their surfaces in SBF.    
              
 
     
(a)             (b) 
Fig. 4.10i SEM images of SBF-treated Hap scaffolds prepared by Co-Precipitation Method.  
             (a) 9.80%, (b) 20.67% porosity. 
 
  The SEM of Hap scaffolds after being soaked in SBF solution for 33 days showed that 
carbonated Hap grew on the surface of porous scaffold and tissue growth was highly prominent in all the 
samples of varied porosities. The growth of carbonated Hap took place so rapidly in porous Hap scaffolds 
due to the presence of high degree of interconnectivity among the pores present in the samples.           31 
Whereas in dense Hap materials, tissue growth is much slower because their specific surface 
areas are much lower in value as compared to their porous counterparts.                                                                                                                                                                                                                         
         
        
(a)             (b) 
Fig. 4.10ii SEM images of SBF-treated Hap scaffolds prepared by Co-Precipitation Method.  
             (a) 48.16%, (b) 54.73% porosity.   
 
        
(a)             (b) 
 
Fig. 4.10iii SEM images of SBF-treated Hap scaffolds prepared by Co-Precipitation Method. 
             (a) 66.32% porosity, (b) 76.07% porosity.                                                                               32                                                                                 
4.2.5.2 EDAX 
 
 
 
Fig. 4.11 Energy Dispersive X-ray Spectroscopy (EDAX) analysis of 76% porosity Hap Scaffold. 
 
Energy dispersive X-ray spectroscopy (EDS or EDX) was another analytical technique which was 
used for the elemental analysis or chemical characterization of the SBF treated scaffold samples. 
The above figure (Fig. 4.11) showed the presence of calcium, oxygen, phosphorous peaks 
only depicting the scaffold to be composed of these materials only. Carbon shown overlapping a calcium 
peak was present because of the in-vitro treatment of the scaffolds with SBF for a long time. Platinum 
shown overlapping a phosphorous peak was the result of Pt coating which was given for secondary 
electron imaging for SEM purposes. This elemental analysis confirmed the formation of carbonated Hap 
on the porous scaffolds, which indicated the bioactivity of the porous scaffolds. 
Accuracy of EDS spectrum could have been affected by many reasons. Windows in front of the 
detector could have absorbed low-energy X-rays (i.e. EDS detectors cannot detect elements with atomic 
number less than 5, that is H, He, Li and Be). Over-voltage settings in EDS alter the peak sizes – raising 
over-voltage on the SEM shifting the spectrum to the larger energies, making higher-energy peaks larger 
and lower-energy peaks smaller. Also many elements would have overlapping peaks. 
        33 
         
 
 
 
 
 
5. CONCLUSIONS 
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Conclusions 
 
 Phase pure Hap was prepared from CaNO3.4H2O and (NH4)2HPO4 by co-precipitation method. 
Hap crystallized at a temperature of 1250
0
C without the appearance of β-TCP phase. 
 The porous scaffolds were prepared by using pore former PEG-600. 
 Porous Hap scaffolds prepared from this method had porosities of 9.80%, 20.67%, 48.16%, 
54.73%, 66.32%, 76.07%.  
 The scaffolds had pore diameters in the range of ~100-400 μm and the pores were inter-
connected. 
 With increase in PEG-600 weights from 0.48 – 2.40 gms per gram of calcined Hap, the bulk 
density decreased and the apparent porosity increased. 
 Increase in porosity from 9.80% to 76.07% led to decrease in compressive strength value from 
8.873 Mpa to 0.179 Mpa. 
 The pore size and pore inter connectivity depended upon the amount of pore former used. 
 The peak volumes of Hg. intruded were achieved at lower pore diameters as the porosity 
increased to higher values as seen in the porosimetry graphs. 
 In-vitro studies of bioactivity showed that the rate of tissue growth takes place rapidly in those 
scaffolds which had higher porosities (48.16%, 54.73%, 66.32% and 76.07% porosity samples). 
 Carbonated Hap was deposited on the porous scaffolds, which indicated the bioactivity of the 
scaffolds studied here in this project. 
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